3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Carboplatin
98
Cisplatin
95
pembrolizumab
90
Gemcitabine
81
Paclitaxel
80
Docetaxel
73
Capecitabine
64
Oxaliplatin
53
Specimen Handling
51
Fluorouracil
51
Magnetic Resonance Spectroscopy
49
Radiotherapy
48
Bevacizumab
48
Dexamethasone
45
Cyclophosphamide
44
Leucovorin
38
Drug Therapy
38
Irinotecan
36
Doxorubicin
36
Pemetrexed
35
Injections
30
Trastuzumab
28
Vincristine
27
Rituximab
27
Radiosurgery
25
Prednisone
25
Etoposide
25
130-nm albumin-bound paclitaxel
25
Radiation
24
Lenalidomide
24
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Recruiting
×
Venlafaxine Hydrochloride
×
Clear all
NCT06106529
2025-02-04
REDFLASH
Reinier de Graaf Groep
Phase 3
Recruiting
260 enrolled